speb/financial-data huggingface dataset:
Stock screener scorecard for 3662.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 257818736 (Micro Cap ($50M-$300M))
P/E ratio: 0.7069408740359897
Debt to equity: 0.053
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3840.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4795453952 (Mid Cap ($2B-$10B))
Debt to equity: 0.13119999999999998
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3840.T (annual, report date 2026-03-31)
Altman Z-score: 3.155210266938016 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -63.50635537497868%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -40.38441170869647%
Free cash flow margin: -20.78997474109304%
Revenue growth: -1.5546370647549215%
Rule of 40 score: -22.34461180584796
Market cap: 4795453952 (Mid Cap ($2B-$10B))
Debt to equity: 0.13119999999999998
Free cash flow (dilution adjusted): -3082926.6766766766
Operating income: -4842630.13013013
Net income: -7986974.474474474
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for 4022.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 73630629888 (Large Cap ($10B-$200B))
P/E ratio: 0.09222637818390125
Debt to equity: 0.23579999999999998
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4424.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2492795136 (Mid Cap ($2B-$10B))
Debt to equity: 0.42840000000000006
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 5976.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 44038340608 (Large Cap ($10B-$200B))
P/E ratio: 0.19753287727143937
Debt to equity: 0.18350000000000002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7241.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 89303040000 (Large Cap ($10B-$200B))
P/E ratio: 0.03342718066644446
Debt to equity: 0.3679
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7367.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 7129711104 (Mid Cap ($2B-$10B))
P/E ratio: 0.07415871893033087
Debt to equity: 0.7044
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7367.T (annual, report date 2026-03-31)
Altman Z-score: 3.5728324968211513 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -378.4670383203792%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 22.591524115233028%
Free cash flow margin: 9.347419446278472%
Revenue growth: 17.892986808883673%
Rule of 40 score: 27.240406255162146
Market cap: 7129711104 (Mid Cap ($2B-$10B))
P/E ratio: 0.07415871893033087
Debt to equity: 0.7044
Free cash flow (dilution adjusted): 6028228.228228228
Operating income: 7270020.02002002
Net income: 3636980.7307307306
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8279.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8173530112 (Mid Cap ($2B-$10B))
Debt to equity: 0.0233
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8410.T (annual, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.64700799674708%
Capitalized R&D asset: 0
Free cash flow margin: 35.69434212236964%
Revenue growth: -3.483958578288869%
Rule of 40 score: 32.21038354408077
Market cap: 362776068096 (Mega Cap (>= $200B))
P/E ratio: 0.1379571499011367
Debt to equity: 0.39682950004191936
Free cash flow (dilution adjusted): 360710710.7107107
Net income: 84703453.45345345
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 8410.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 362776068096 (Mega Cap (>= $200B))
P/E ratio: 0.1379571499011367
Debt to equity: 0.39682950004191936
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8704.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 33555771392 (Large Cap ($10B-$200B))
P/E ratio: 0.0403103141304388
Debt to equity: 0.0603
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8704.T (annual, report date 2026-03-31)
Altman Z-score: 0.6374549534472649 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 24.169867915592274%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 30.44552010273634%
Free cash flow margin: -11.085048426150122%
Revenue growth: -7.871738285798462%
Rule of 40 score: -18.956786711948585
Market cap: 33555771392 (Large Cap ($10B-$200B))
P/E ratio: 0.0403103141304388
Debt to equity: 0.0603
Free cash flow (dilution adjusted): -9165415.415415416
Operating income: 38563563.56356356
Net income: 26551551.55155155
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 9658.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 33494493184 (Large Cap ($10B-$200B))
P/E ratio: 0.06334416980804813
Debt to equity: 0.1057
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 9828.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 59512602624 (Large Cap ($10B-$200B))
P/E ratio: 0.09098801561646573
Debt to equity: 1.5781
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for A7A.DE (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 130670640 (Micro Cap ($50M-$300M))
P/E ratio: 1.4299642508937276
Debt to equity: 0.30920000000000003
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for A7A.DE (annual, report date 2025-12-31)
Altman Z-score: 2.7809777574873475 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 157.48753573549516%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.330000518054188%
Free cash flow margin: -161.0792192881745%
Revenue growth: -73.18108922958496%
Rule of 40 score: -234.26030851775946
Market cap: 130670640 (Micro Cap ($50M-$300M))
P/E ratio: 1.4299642508937276
Debt to equity: 0.30920000000000003
Free cash flow (dilution adjusted): -1650588.2352941176
Operating income: -11729411.764705883
Net income: 125808235.29411764
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for AAR.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 252146384 (Micro Cap ($50M-$300M))
Debt to equity: 0.0021
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AARTECH.NS (annual, report date 2026-03-31)
Altman Z-score: 7.698167147503857 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 11.956527932085576%
Capitalized R&D asset: 40486.28932793318
ROCI (R&D adjusted): 14.950377453992067%
Rosenberg metric: -4.478088553995927
Free cash flow margin: -3.03344568317345%
Revenue growth: 1.9544341799353742%
Rule of 40 score: -1.079011503238076
Market cap: 1522754176 (Small Cap ($300M-$2B))
P/E ratio: 0.2937328550327073
Debt to equity: 0.1602
Free cash flow (dilution adjusted): -131432.8105129292
Operating income: 595050.8690122934
Net income: 429048.3255616787
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for AARTECH.NS (quarterly, report date 2026-03-31)
Altman Z-score: 6.958000010752733 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.31119847306498%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.7960438280694486%
Revenue growth: 125.06489463182555%
Rule of 40 score: 125.06489463182555
Market cap: 1522754176 (Small Cap ($300M-$2B))
P/E ratio: 0.2937328550327073
Debt to equity: 0.1602
Operating income: 143704.9597286986
Net income: 72424.75625264943
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ADOC.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 79149104 (Micro Cap ($50M-$300M))
Debt to equity: 5.9704999999999995
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ADOC.PA (annual, report date 2025-12-31)
Altman Z-score: -0.6695566620654898 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1096.1770623742455%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -186.94259962049335%
Free cash flow margin: -460.81355932203394%
Revenue growth: -82.12764346163311%
Rule of 40 score: -542.941202783667
Market cap: 79149104 (Micro Cap ($50M-$300M))
Debt to equity: 5.9704999999999995
Free cash flow (dilution adjusted): -7996470.588235294
Operating income: -18544705.88235294
Net income: -19518823.529411767
Long score: 0 | Short score: 12
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AIMD (quarterly, report date 2026-03-31)
Altman Z-score: -4.554278020664534 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 3769350.7600000002
ROCI (R&D adjusted): -12.963036894791244%
Rosenberg metric: -0.0047676730759992425
Free cash flow margin: -616126.0869565217%
Revenue growth: -98.5521582733813%
Rule of 40 score: -616224.6391147951
Market cap: 10310359 (Nano Cap (< $50M))
Debt to equity: 2.4268
Free cash flow (dilution adjusted): -991963
Operating income: -2283647
Net income: -2459800
Long score: 0 | Short score: 17
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ALKLA.PA (quarterly, report date 2025-06-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1387944 (Nano Cap (< $50M))
Debt to equity: 0.742
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ANAB (quarterly, report date 2026-03-31)
Altman Z-score: 0.25961772670268324 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -410.222013022672%
Capitalized R&D asset: 61479840
ROCI (R&D adjusted): -8.860767172747675%
Free cash flow margin: -157.12161527625605%
Revenue growth: -76.39146781956416%
Rule of 40 score: -233.5130830958202
Market cap: 1603299200 (Small Cap ($300M-$2B))
Debt to equity: 21.758499999999998
Free cash flow (dilution adjusted): -40154000
Operating income: -34637000
Net income: -52884000
Long score: 0 | Short score: 13
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ARM.MC (annual, report date 2025-12-31)
Altman Z-score: 0.7902667783424975 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.42843150118546%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.0640033851595474%
Free cash flow margin: -173.17970355945042%
Revenue growth: 59.036455532853%
Rule of 40 score: -114.14324802659742
Market cap: 254358096 (Micro Cap ($50M-$300M))
P/E ratio: 25.721925133689837
Debt to equity: 0.7304
Free cash flow (dilution adjusted): -56495294.11764706
Operating income: 19934117.647058822
Net income: 9845882.352941176
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for ARM.MC (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 254358096 (Micro Cap ($50M-$300M))
P/E ratio: 25.721925133689837
Debt to equity: 0.7304
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CELZ (quarterly, report date 2026-03-31)
Altman Z-score: -5.074898617269321 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.17016253689678%
Capitalized R&D asset: 1063710.4100000001
ROCI (R&D adjusted): -19.960124688270948%
Rosenberg metric: -0.0036467621805674477
Revenue growth: -100%
Rule of 40 score: -100
Market cap: 5255773 (Nano Cap (< $50M))
Debt to equity: 0.0023
Free cash flow (dilution adjusted): -1448310
Operating income: -1459153
Net income: -1403717
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CEVA (quarterly, report date 2026-03-31)
Altman Z-score: 12.935560208394545 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.1193016662664377%
Capitalized R&D asset: 38968340
ROCI (R&D adjusted): -1.171109337092088%
Rosenberg metric: -0.2253089679940847
Free cash flow margin: -46.52161042036708%
Revenue growth: -13.636508900322777%
Rule of 40 score: -60.15811932068986
Market cap: 1012688000 (Small Cap ($300M-$2B))
Debt to equity: 0.0499
Free cash flow (dilution adjusted): -12572000
Operating income: -5085000
Net income: -4459000
Long score: 4 | Short score: 15
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CHR (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3635542 (Nano Cap (< $50M))
P/E ratio: 0.05317823016202742
Debt to equity: 0.0256
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CHR (annual, report date 2025-12-31)
Altman Z-score: 2.8761380415994227 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.74028882008903%
Capitalized R&D asset: 1129510.7334836137
ROCI (R&D adjusted): 7.43879110746217%
Rosenberg metric: 0.6840223370561738
Free cash flow margin: 9.272684516410791%
Revenue growth: 5.446916259370412%
Rule of 40 score: 14.719600775781203
Market cap: 3635542 (Nano Cap (< $50M))
P/E ratio: 0.05317823016202742
Debt to equity: 0.0256
Free cash flow (dilution adjusted): 1971571.4285714286
Operating income: 3755428.5714285714
Net income: 3660142.8571428573
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for CIFL.NS (annual, report date 2026-03-31)
Altman Z-score: 1.549846425314079 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.340992482652304%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.712654436469015%
Free cash flow margin: -51.559097923571706%
Revenue growth: -12.51219383618582%
Rule of 40 score: -64.07129175975753
Market cap: 7840678400 (Mid Cap ($2B-$10B))
P/E ratio: 0.2188225364000844
Debt to equity: 1.3921999999999999
Free cash flow (dilution adjusted): -27986339.55065706
Operating income: -5260777.871979652
Net income: 4121598.1348028826
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CIFL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.3886032001707527 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.167266504212069%
Revenue growth: -18.82050025849734%
Rule of 40 score: -18.82050025849734
Market cap: 7840678400 (Mid Cap ($2B-$10B))
P/E ratio: 0.2188225364000844
Debt to equity: 1.3921999999999999
Operating income: -2263734.6333192033
Net income: -16606.612971598133
Long score: 0 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for CPSH (quarterly, report date 2026-03-31)
Altman Z-score: 10.67417011671022 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.536717131384605%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.1259566487633115%
Free cash flow margin: -11.628557461442636%
Revenue growth: -14.367543440932684%
Rule of 40 score: -25.996100902375318
Market cap: 85551912 (Micro Cap ($50M-$300M))
P/E ratio: 2385.198276238705
Debt to equity: 0.0123
Free cash flow (dilution adjusted): -817342
Operating income: -522634
Net income: -294179
Long score: 4 | Short score: 14
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for DEA (quarterly, report date 2026-03-31)
Altman Z-score: 0.30181509229268016 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.0943308570943575%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7249426814101642%
Free cash flow margin: 27.568955158665137%
Revenue growth: 5.176989625340365%
Rule of 40 score: 32.7459447840055
Market cap: 1219223296 (Small Cap ($300M-$2B))
P/E ratio: 95.54545454545455
Debt to equity: 1.2669
Free cash flow (dilution adjusted): 25238000
Operating income: 20565000
Net income: 1414000
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for E3B.DE (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2407464192 (Mid Cap ($2B-$10B))
Debt to equity: 0.7414000000000001
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for E79.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 9546004 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for E79.AX (annual, report date 2025-06-30)
Altman Z-score: 13.149804415548486 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -31.398841866051143%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -34.358348585812024%
Free cash flow margin: -654.8040990797604%
Rule of 40 score: -654.8040990797604
Market cap: 9546004 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1146399.3464052288
Operating income: -1260791.503267974
Net income: -1217249.6732026143
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for EMV.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 143125456 (Micro Cap ($50M-$300M))
Debt to equity: 0.1764
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for EMV.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -108.86996275747276%
Capitalized R&D asset: 5175147.2550508585
ROCI (R&D adjusted): -65.28564015086205%
Rule of 40 score: 0
Market cap: 143125456 (Micro Cap ($50M-$300M))
Debt to equity: 0.1764
Free cash flow (dilution adjusted): -5154490.196078431
Operating income: -9081878.43137255
Net income: -6408847.05882353
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for HE1.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 40028976 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HRTG (quarterly, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.691024934465935%
Capitalized R&D asset: 0
Free cash flow margin: 9.7079090725079%
Revenue growth: 59.57224207784183%
Rule of 40 score: 69.28015115034972
Market cap: 842209408 (Small Cap ($300M-$2B))
P/E ratio: 4.0260736196319025
Debt to equity: 0.19030000000000002
Free cash flow (dilution adjusted): 22062000
Net income: 36483000
Long score: 4 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for IBG (annual, report date 2024-12-31)
Altman Z-score: -2.8528083670921616 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -93.32176062475082%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -96.56547649955715%
Free cash flow margin: -92.22694945454882%
Revenue growth: -15.554448473822328%
Rule of 40 score: -107.78139792837115
Market cap: 1661350 (Nano Cap (< $50M))
Debt to equity: 0.2687
Free cash flow (dilution adjusted): -1679127.950310559
Operating income: -1605570.1863354037
Net income: -1597101.2422360247
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for LNAI (quarterly, report date 2026-03-31)
Altman Z-score: -74.73726403446919 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 54734.55
Free cash flow margin: -5710.29032566135%
Rule of 40 score: -5710.29032566135
Market cap: 10563963 (Nano Cap (< $50M))
Debt to equity: -0.1477340908415283
Free cash flow (dilution adjusted): -1195849
Operating income: -1427260
Net income: -2571394
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for LUCD (quarterly, report date 2026-03-31)
Altman Z-score: -9.853132511737089 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -366.8073878627968%
Capitalized R&D asset: 2780170
ROCI (R&D adjusted): -164.65623301320684%
Rosenberg metric: -0.0075449796865931515
Free cash flow margin: -1092.9140127388537%
Revenue growth: -16.48936170212766%
Rule of 40 score: -1109.4033744409812
Market cap: 173144240 (Micro Cap ($50M-$300M))
Debt to equity: 6.7008
Free cash flow (dilution adjusted): -13727000
Operating income: -12114000
Net income: -13909000
Long score: 0 | Short score: 13
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for NAN (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 370550752 (Small Cap ($300M-$2B))
P/E ratio: 31.5
Debt to equity: 0.659
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NANO.L (quarterly, report date 2026-01-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4652254 (Nano Cap (< $50M))
P/E ratio: 0.08333333333333333
Debt to equity: -0.044328097731239094
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for NHI (quarterly, report date 2026-03-31)
Altman Z-score: 3.146866296922862 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.21138452905547%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.0894817186894605%
Free cash flow margin: 44.47146703726222%
Revenue growth: 8.794874460183514%
Rule of 40 score: 53.26634149744574
Market cap: 3903860736 (Mid Cap ($2B-$10B))
P/E ratio: 25.7741935483871
Debt to equity: 0.9756999999999999
Free cash flow (dilution adjusted): 51200000
Operating income: 52095000
Net income: 40102000
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NILI.V (quarterly, report date 2026-03-31)
Altman Z-score: 569.1922608811585 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.11673579650725%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -11.262766707706282%
Rule of 40 score: 0
Market cap: 150700224 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -3391087.0503597124
Operating income: -3389323.021582734
Net income: -3345377.6978417267
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for PNBGILTS.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 5.036459788982167%
Rule of 40 score: 5.036459788982167
Market cap: 15392666624 (Large Cap ($10B-$200B))
P/E ratio: 0.17137586570164737
Debt to equity: 14.802200000000001
Operating income: 46290906.213735625
Net income: 8513345.289587509
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SAFE (quarterly, report date 2026-03-31)
Altman Z-score: 0.6154744768089319 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.4025837921353743%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.0995118967325184%
Free cash flow margin: -11.16603821242355%
Revenue growth: 13.265420809024123%
Rule of 40 score: 2.0993825966005737
Market cap: 1185861504 (Small Cap ($300M-$2B))
P/E ratio: 8.468354430379748
Debt to equity: 1.9103999999999999
Free cash flow (dilution adjusted): -12378000
Operating income: 79700000
Net income: 28897000
Long score: 0 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for TBR.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 253945488 (Micro Cap ($50M-$300M))
P/E ratio: 3.5987085597291126
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TPVG (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.7550907604158654%
Capitalized R&D asset: 0
Free cash flow margin: -85.33368855734648%
Revenue growth: -22.656089017102822%
Rule of 40 score: -107.9897775744493
Market cap: 180259472 (Micro Cap ($50M-$300M))
P/E ratio: 4.552380952380952
Debt to equity: 1.2712
Free cash flow (dilution adjusted): -6406000
Net income: 6160000
Long score: 0 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for TRU.V (quarterly, report date 2025-12-31)
Altman Z-score: -0.7781598907481833 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.973879262392426%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.757372829901441%
Rule of 40 score: 0
Market cap: 5789764 (Nano Cap (< $50M))
P/E ratio: 633.1157534133155
Debt to equity: 0
Free cash flow (dilution adjusted): 57332.846715328466
Operating income: -31624.087591240874
Net income: -11169.34306569343
Long score: 4 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for TRU.V (annual, report date 2025-12-31)
Altman Z-score: -1.4918495802261926 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.6524774668701575%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -28.532587596309167%
Rule of 40 score: 0
Market cap: 5789764 (Nano Cap (< $50M))
P/E ratio: 806.778277409286
Debt to equity: 0
Free cash flow (dilution adjusted): 147292.700729927
Operating income: -327237.95620437956
Net income: 7483.211678832116
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for TVA (quarterly, report date 2026-03-31)
Altman Z-score: 16.49476283149147 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.21116652057626964%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.0832762622185201%
Rule of 40 score: 0
Market cap: 315600000 (Small Cap ($300M-$2B))
P/E ratio: 43.29166666666667
Debt to equity: 0
Free cash flow (dilution adjusted): -382498
Operating income: -2521284
Net income: -472477
Long score: 4 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for USS.V (quarterly, report date 2026-02-28)
Altman Z-score: -2.584981568877388 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.488174206877912%
Free cash flow margin: -44.55416342960014%
Revenue growth: 33.862727597610245%
Rule of 40 score: -10.691435831989892
Market cap: 25557770 (Nano Cap (< $50M))
Debt to equity: 2.1618
Free cash flow (dilution adjusted): -892048.1751824816
Operating income: -497910.9489051094
Net income: -1132293.4306569342
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for UZU.DE (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 304676864 (Small Cap ($300M-$2B))
P/E ratio: 15.294117647058826
Debt to equity: 0.273
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for VINO.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13321432 (Nano Cap (< $50M))
Debt to equity: 0.0966
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ZEELEARN.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.3181854659962495 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 41.069381052601386%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.038231336935093%
Revenue growth: 111.08852767177963%
Rule of 40 score: 111.08852767177963
Market cap: 2628405248 (Mid Cap ($2B-$10B))
P/E ratio: 0.03832537067396742
Debt to equity: 1.6122
Operating income: 4384707.503179314
Net income: 4813215.345485375
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ZEELEARN.NS (annual, report date 2026-03-31)
Altman Z-score: 0.5213935189164438 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 49.938797242111235%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.752918663583003%
Free cash flow margin: 21.55947516427593%
Revenue growth: 7.013430293988448%
Rule of 40 score: 28.57290545826438
Market cap: 2628405248 (Mid Cap ($2B-$10B))
P/E ratio: 0.03832537067396742
Debt to equity: 1.6122
Free cash flow (dilution adjusted): 10031761.339550657
Operating income: 6355998.304366257
Net income: 4082821.1106401016
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0571.HK (annual, report date 2025-07-31)
Altman Z-score: -4.722673178672515 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -20.602188336922254%
Free cash flow margin: 22.134200777826806%
Revenue growth: -33.56657554964073%
Rule of 40 score: -11.432374771813926
Market cap: 87793843.30000001 (Micro Cap ($50M-$300M))
Debt to equity: 24.713251844887075
Free cash flow (dilution adjusted): 21982165.605095543
Operating income: -12602292.993630573
Net income: -1630573.2484076433
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 4424.T (annual, report date 2025-09-30)
Altman Z-score: 3.893956984492207 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -41.150453697099444%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -40.42759908202021%
Free cash flow margin: -15.94143870848611%
Revenue growth: -23.840144642256682%
Rule of 40 score: -39.78158335074279
Market cap: 1907415839.9999998 (Small Cap ($300M-$2B))
Debt to equity: 0
Free cash flow (dilution adjusted): -3050087.4831763124
Operating income: -2497759.0847913865
Net income: -2505181.6958277253
Long score: 4 | Short score: 13
Recommendation: Short
Stock screener scorecard for AIMD (annual, report date 2025-12-31)
Altman Z-score: -6.187302126338692 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 15801838.45
ROCI (R&D adjusted): -39.52227775812191%
Rosenberg metric: 0.01601833056946207
Free cash flow margin: -5136.4908945931365%
Revenue growth: 498.9531574123209%
Rule of 40 score: -4637.537737180815
Market cap: 12077848.879999999 (Nano Cap (< $50M))
Debt to equity: 1.4545296831161632
Free cash flow (dilution adjusted): -6377313
Operating income: -13990408
Net income: -14771012
Long score: 0 | Short score: 13
Recommendation: Short
Stock screener scorecard for ALKLA.PA (annual, report date 2024-12-31)
Altman Z-score: 1.177510280267084 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.082138918538005%
Free cash flow margin: -6.101201050075324%
Revenue growth: 18.354414967898112%
Rule of 40 score: 12.253213917822787
Market cap: 4529082.640000001 (Nano Cap (< $50M))
Debt to equity: 0.2311999068875145
Free cash flow (dilution adjusted): -390860.4166666667
Operating income: -249785.4166666667
Net income: -47189.583333333336
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for BLFS (annual, report date 2025-12-31)
Altman Z-score: 20.1163724354776 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -5.901511531400116%
Capitalized R&D asset: 28090120
ROCI (R&D adjusted): -1.1271828888544142%
Rosenberg metric: 2.5304146495474638
Free cash flow margin: -23.465400045731393%
Revenue growth: 28.89198494246252%
Rule of 40 score: 5.4265848967311285
Market cap: 1181372294.7 (Small Cap ($300M-$2B))
Debt to equity: 0.04812470421202082
Free cash flow (dilution adjusted): -22577000
Operating income: -16602000
Net income: -4595000
Long score: 6 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for CELZ (annual, report date 2025-12-31)
Altman Z-score: 12.62292636670403 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -82.61345369589365%
Capitalized R&D asset: 4518627.46
ROCI (R&D adjusted): -50.596065315622695%
Rosenberg metric: -0.0011637898896898796
Free cash flow margin: -97665.5%
Revenue growth: -45.45454545454545%
Rule of 40 score: -97710.95454545454
Market cap: 12714535.68 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -5859930
Operating income: -6142814
Net income: -5995008
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for CEVA (annual, report date 2025-12-31)
Altman Z-score: 7.922136847443192 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.3525077046328846%
Capitalized R&D asset: 146803090
ROCI (R&D adjusted): -1.8877273609028422%
Rosenberg metric: 0.017719504021447723
Free cash flow margin: -23.78966769466596%
Revenue growth: 2.486464245972003%
Rule of 40 score: -21.30320344869396
Market cap: 599533620.88 (Small Cap ($300M-$2B))
Debt to equity: 0.047943576910045235
Free cash flow (dilution adjusted): -26073000
Operating income: -11346000
Net income: -10638000
Long score: 4 | Short score: 13
Recommendation: Short
Stock screener scorecard for CITI.TO (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.93229544383804%
Capitalized R&D asset: 0
Free cash flow margin: -87.0195862133712%
Revenue growth: 10.255052811854865%
Rule of 40 score: -76.76453340151633
Market cap: 257801750320.64 (Mega Cap (>= $200B))
P/E ratio: 17.838482585153614
Debt to equity: 1.7196780499667963
Free cash flow (dilution adjusted): -54125547445.25547
Net income: 10548905109.48905
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for DEA (annual, report date 2025-12-31)
Altman Z-score: 0.38013329626374254 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 11.187820449236803%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.987376890582303%
Free cash flow margin: 75.31977185293619%
Revenue growth: 11.27190020261412%
Rule of 40 score: 86.5916720555503
Market cap: 946638242.12 (Small Cap ($300M-$2B))
P/E ratio: 69.82652814929557
Debt to equity: 1.2166819391558634
Free cash flow (dilution adjusted): 253149000
Operating income: 85195000
Net income: 13557000
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for E3B.DE (annual, report date 2025-06-30)
Altman Z-score: 0.2919472203360207 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.541614673253449%
Free cash flow margin: -0.450269357562113%
Revenue growth: 12.18088356529752%
Rule of 40 score: 11.730614207735407
Market cap: 3380343718.57 (Mid Cap ($2B-$10B))
Debt to equity: 1.1906354515050166
Free cash flow (dilution adjusted): -6588235.294117647
Operating income: -1069647058.8235295
Net income: -1272823529.4117646
Long score: 0 | Short score: 8
Recommendation: Short
Stock screener scorecard for GUD.TO (annual, report date 2025-12-31)
Altman Z-score: 2.1626092921307714 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 36462111.722219385
ROCI (R&D adjusted): 0.3715765254212173%
Rosenberg metric: 1.4844746429922742
Free cash flow margin: 6.031931533389026%
Revenue growth: 26.527019157261645%
Rule of 40 score: 32.55895069065067
Market cap: 593985134.0500001 (Small Cap ($300M-$2B))
Debt to equity: 0.10154286876101302
Free cash flow (dilution adjusted): 19816788.321167883
Operating income: -1715328.4671532845
Net income: -3922627.737226277
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for HE1.L (annual, report date 2025-06-30)
Altman Z-score: -0.4672134730249886 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -38.14932685839162%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.922151233748827%
Rule of 40 score: 0
Market cap: 985935.3797000002 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -27018773.97260274
Operating income: -5773712.328767124
Net income: -7533813.698630137
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for HRTG (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 42.816095583313334%
Capitalized R&D asset: 0
Free cash flow margin: 21.793577211626616%
Revenue growth: 1.0103249839568844%
Rule of 40 score: 22.8039021955835
Market cap: 885803341.5 (Small Cap ($300M-$2B))
P/E ratio: 4.528785859995706
Debt to equity: 0.19755527450712615
Free cash flow (dilution adjusted): 168776000
Net income: 195594000
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for LNAI (annual, report date 2025-06-30)
Altman Z-score: -96.23347906778967 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 3726858.4400000004
Rule of 40 score: 0
Market cap: 104823536.80000001 (Micro Cap ($50M-$300M))
Debt to equity: -0.47651366583947863
Free cash flow (dilution adjusted): -11187938
Operating income: -18546573
Net income: -178007489
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for LUCD (annual, report date 2025-12-31)
Altman Z-score: -8.938301491438525 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -539.8267583090105%
Capitalized R&D asset: 12085800
ROCI (R&D adjusted): -209.90334936753965%
Rosenberg metric: 0.13167556742323097
Free cash flow margin: -1087.3990650233743%
Revenue growth: 8.283479061205707%
Rule of 40 score: -1079.1155859621686
Market cap: 207940981.87 (Micro Cap ($50M-$300M))
Debt to equity: 2.36100950987564
Free cash flow (dilution adjusted): -51173000
Operating income: -49640000
Net income: -58010000
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for NAN (annual, report date 2025-08-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.854178962213557%
Capitalized R&D asset: 0
Revenue growth: -181.3835981104084%
Rule of 40 score: -181.3835981104084
Market cap: 339891316.5 (Small Cap ($300M-$2B))
Debt to equity: 0.0011506608178953504
Free cash flow (dilution adjusted): 24754332
Net income: -23149710
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for NANO.L (annual, report date 2025-07-31)
Altman Z-score: 3.25645443771748 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 3079256.4102564105
ROCI (R&D adjusted): -9.152650393594618%
Rosenberg metric: 0.7184525205158269
Free cash flow margin: -78.41953268574429%
Revenue growth: 0.6187452374904893%
Rule of 40 score: -77.8007874482538
Market cap: 237173.729 (Nano Cap (< $50M))
Debt to equity: -0.06654362760176358
Free cash flow (dilution adjusted): -7965333.333333334
Operating income: -2149333.3333333335
Net income: -2929333.3333333335
Long score: 3 | Short score: 12
Recommendation: Short
Stock screener scorecard for NHI (annual, report date 2025-12-31)
Altman Z-score: 3.46915300892049 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.664127139357873%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.624380030067392%
Free cash flow margin: 61.493552131364005%
Revenue growth: 12.067211446949559%
Rule of 40 score: 73.56076357831357
Market cap: 3616911914.98 (Mid Cap ($2B-$10B))
P/E ratio: 25.439500868494903
Debt to equity: 0.7557704895889614
Free cash flow (dilution adjusted): 230987000
Operating income: 190588000
Net income: 142177000
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for NILI.V (annual, report date 2025-12-31)
Altman Z-score: 548.4321062175494 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -38.221201747270165%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -37.85571319281315%
Rule of 40 score: 0
Market cap: 183351937.01 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -4944841.605839416
Operating income: -4811731.386861313
Net income: -4858187.591240875
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for PNBGILTS.NS (annual, report date 2025-03-31)
Altman Z-score: 0.428205260951941 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 15.239468063611703%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 104.52645758140432%
Free cash flow margin: -11.806248473657591%
Revenue growth: 18.0982904267966%
Rule of 40 score: 6.292041953139007
Market cap: 14318099750.179075 (Large Cap ($10B-$200B))
P/E ratio: 6.144297618373491
Debt to equity: 14.486167570056523
Free cash flow (dilution adjusted): -23131961.65536591
Operating income: 189486696.28244096
Net income: 27242307.692307692
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SAFE (annual, report date 2025-12-31)
Altman Z-score: 0.7271165085643484 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.692795202094094%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.377129559908291%
Free cash flow margin: 9.14662613603353%
Revenue growth: 5.432817862367885%
Rule of 40 score: 14.579443998401416
Market cap: 957425726.7399999 (Small Cap ($300M-$2B))
P/E ratio: 8.352313763761668
Debt to equity: 1.8408736662760736
Free cash flow (dilution adjusted): 35265000
Operating income: 311344000
Net income: 114630000
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TPVG (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.915180376731021%
Capitalized R&D asset: 0
Free cash flow margin: -99.39872424971243%
Revenue growth: 26.01686725819204%
Rule of 40 score: -73.3818569915204
Market cap: 243187896.19 (Micro Cap ($50M-$300M))
P/E ratio: 4.942140268457741
Debt to equity: 1.3265049304198562
Free cash flow (dilution adjusted): -57033000
Net income: 49207000
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for TVA (annual, report date 2025-12-31)
Altman Z-score: 15.504831498039918 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.643143692875569%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.3082660894961203%
Rule of 40 score: 0
Market cap: 239625000 (Micro Cap ($50M-$300M))
P/E ratio: 40.43334079708478
Debt to equity: 0
Free cash flow (dilution adjusted): -437989
Operating income: -718934
Net income: 5926421
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for USS.V (annual, report date 2024-05-31)
Altman Z-score: -13.14770884318038 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -30.38244003846804%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -36.047849368453384%
Free cash flow margin: -6.919864262367283%
Revenue growth: -2.1969903032708498%
Rule of 40 score: -9.116854565638132
Market cap: 3594061.53 (Nano Cap (< $50M))
Debt to equity: 0.7770042171585159
Free cash flow (dilution adjusted): -325243.0656934306
Operating income: -174735.76642335765
Net income: -139489.7810218978
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for VINO.L (annual, report date 2025-06-30)
Altman Z-score: 2.1872532573224337 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 22.38302406108497%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.035165903658388%
Free cash flow margin: 1.9552362718354483%
Revenue growth: 8.248523169037243%
Rule of 40 score: 10.203759440872691
Market cap: 271186.30079999997 (Nano Cap (< $50M))
P/E ratio: 0.20828440921658986
Debt to equity: 0.09694960212201591
Free cash flow (dilution adjusted): 1580821.9178082193
Operating income: 1364383.5616438356
Net income: 1783561.6438356165
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 0071.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6944144896 (Mid Cap ($2B-$10B))
P/E ratio: 1.293216515397933
Debt to equity: 0.0025
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0538.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 916892608 (Small Cap ($300M-$2B))
P/E ratio: 3.2562125107112254
Debt to equity: 0.2249
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0538.HK (annual, report date 2025-12-31)
Altman Z-score: 1.935927004025278 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.408302579089957%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.902767036862435%
Free cash flow margin: 20.22194006777529%
Revenue growth: 6.401752351454798%
Rule of 40 score: 26.62369241923009
Market cap: 916892608 (Small Cap ($300M-$2B))
P/E ratio: 3.2562125107112254
Debt to equity: 0.2249
Free cash flow (dilution adjusted): 47616066.83804627
Operating income: 8440745.501285346
Net income: 4150128.53470437
Long score: 8 | Short score: 1
Recommendation: Long